A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons.

A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons. Abstract Text:

A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons. Publishing Authors By Initials

For similar musculoskeletal system: tendons research abstracts see: musculoskeletal system: tendons research

PUBMED ID PMID:

MEDLINE DATE:

A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Matrix (Stuttgart, Germany). Supplement

VOLUME: 1

Page Numbers: 97-8

Journal Abbreviation:

ISSN: 0940-1199

DAY: 26

MONTH: 02

YEAR: 1992

A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9312140

A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons. Keywords Mesh Terms:

KEYWORDS: Tendons

MESH TERMS: enzymology

Chemical & Substance for Abstract: A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons. Information

Substance Name: Procollagen N-Endopeptidase

Registry Number: EC 3.4.24.14

Grant and Affiliation Information for A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons.

AFFILIATION: Thomas Jefferson University, Philadelphia, PA 19107.

Country: GERMANY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Matrix Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons Related Publications

• A new 500-kDa form of type I procollagen N-proteinase from chick embryo tendons.
• Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
• Assays of MSCs with Microarrays.
• Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension.
• Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
• Environmental Neurology Research Group (ENRG) of the World Federation of Neurology (WFN).
• Histamine receptor H1 and dermatopontin: new downstream targets of the vitamin D receptor.
• Human multipotent stromal cells undergo sharp transition from division to development in culture.
• Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice.
• Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment.
• Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.
• Mutations in collagen genes as a cause of rare and perhaps common diseases of connective tissue.
• Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies.
• Stem cells and cell therapies in lung biology and lung diseases.
• Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses.
• The Gordon Wilson lecture. Mutations in type I procollagen genes. An explanation for brittle bones and a paradigm for other diseases of connective tissue.
• The allegory of a mountain: an environmental introduction to neurotoxicology.